Hi all,
This morning we announced Monash Health has been established as the first clinical site for our MagSense HER2 breast cancer Phase I study, and the study is now open for enrolment of patients.
We also announced the appointment of Dr Jane Fox as the Principal Investigator for the study. Dr Fox is a highly regarded clinician who currently serves as Director of Breast Services at Monash Health. She is also a senior lecturer at the Monash University Department of Surgery and leads the multi-disciplinary team at the Monash Cancer Centre.
We are now in an exciting position where, after all the diligence and hard work, we are now ready to commence enrolling patients. We look forward to providing further updates in coming weeks.
You can view the ASX announcement
here
